The Raman spectroscopy of pharmaceutical cocrystals based on caffeine and oxalic acid in nanosized pores of mesoporous silica has been demonstrated at various molar amounts. The Raman peak shifts of caffeine molecules express the existence of pharmaceutical cocrystals in mesoporous silica. The molar amount dependence of the peak shifts describes that caffeine and oxalic acid cocrystallized on the surface of the nanosized pores and piled up layer by layer. This is the first report that shows the Raman spectroscopy is a powerful tool to observe the synthesis of pharmaceutical cocrystals incorporated in the nanosized pores of mesoporous silica. The results indicate a way to control the size of cocrystals on a nanometer scale, which will provide higher bioavailability of pharmaceuticals.
Introduction
Pharmaceutical cocrystals are molecular crystals composed of active pharmaceutical ingredients (APIs) and several kinds of accessory molecules, called coformers. [1] [2] [3] [4] [5] [6] The physicochemical properties of cocrystals are determined by not only their constituent species, but also by the intermolecular bonds between the APIs and coformers. Therefore, the appropriate selection of coformers improves the physicochemical properties of pharmaceuticals, such as the solubility, solution stability, and processability, without altering the nature of the APIs. For example, caffeine, which is well known as a nervous-system stimulants and diuretic agent, is less soluble in water in the pure-crystal form. However, a larger amount of caffeine can be dissolved in water when it forms cocrystals with organic acids. 7 Higher solubility provides higher bioavailability of the APIs, and expands the usability of poorly soluble APIs in the pharmaceutical industry.
The down-sizing of cocrystals to a nanometer scale is a prospective approach for further improving the solubility of APIs. Shchekin and Rusanov showed that the solubility of crystals is exponentially enhanced when the particle size is a few nanometers. 8 Down-sizing enables us to further engineer material properties while keeping their original physicochemical characteristics, which will be applied to various kinds of medicines and cosmetics. So far, small particles of cocrystals have been produced by a spray flash evaporation process. 9 However, the smallest particle size with this method is on the order of several tens of nanometers. Further down-sizing is difficult with this method, although this technique can be used in mass production.
Mesoporous structures have been widely investigated as host materials to form nanometer-scale molecular crystals. 10, 11 They have nanometer-scale pores containing many functional groups that can capture molecules on their surfaces. If the interaction between molecules and the surfaces of pores is stronger than the intermolecular interaction of molecular crystals, molecules are preferentially adsorbed on the surfaces and cocrystallize in the pores, [12] [13] [14] [15] which decreases the size of cocrystals to a nanometer scale.
The analysis of pharmaceutical cocrystals becomes very difficult when their size approaches to a nanometer scale. Electron microscopy provides the images of crystal structures with a spatial resolution of few nanometers, 11 but does not reveal the physicochemical properties of cocrystals, and seriously damages them. Spectroscopic methods are non-destructive techniques to resolve molecular bonds in cocrystals, and to explain their physicochemical properties. X-ray photoelectron spectroscopy is not suitable for cocrystals incorporated in porous materials, because X-ray can only reach the sample surfaces. 16 Fluorescence spectroscopy is inappropriate concerning cocrystals in nanosized pores because the fluorescence labels are not fully controlled in such small pores. Near-infrared absorption spectroscopy 17 and terahertz absorption spectroscopy 4 can be used to analyze cocrystal formation, but the detection sensitivity is quite low for nanometer-scale cocrystals or cocrystals incorporated in nanosized porous materials. Therefore, highly sensitive and non-destructive approaches are desired to analyze nanometer-scale pharmaceutical cocrystals in mesoporous silica.
Raman spectroscopy is a well-known spectroscopic method for identifying molecular compositions from the vibration frequencies of the molecular bonds. [18] [19] [20] [21] [22] [23] [24] [25] Recent improvements in optical filters make it possible to extract small Raman shifts and directly distinguish intermolecular bonds in addition to intramolecular bonds. 26, 27 Moreover, Raman peak deformations in intramolecular bonds reveal the adsorption of molecular crystals on the surfaces, 28, 29 which play an important role in cocrystallization in porous materials. By following the Raman peak of the fingerprint band, the transformation of carbamazepine and cocrystallization with nicotinamide has been investigated. 30, 31 Raman spectroscopy has a potential method to analyze pharmaceutical cocrystals in mesoporous silica both noninvasively and non-destructively as well as with high resolution in frequency and spatial regions.
In this paper, we report on the Raman spectroscopic analysis of caffeine-oxalic acid cocrystals incorporated in nanosized pores of mesoporous silica (SBA-16). The Raman peak shifts of caffeine, oxalic acid, and their cocrystals indicate the adsorption of each molecule on the surface of SBA-16. Differences in the Raman spectra and the variations of compositions at various molar amounts explain the cocrystallization of caffeine and oxalic acid in SBA-16. We found that the cocrystallization begins after molecules fully occupy the surface of SBA-16. This is the first report of observing the synthesis of pharmaceutical cocrystals in mesoporous silica by Raman spectroscopy. It indicates that Raman spectroscopy is a powerful tool to analyze pharmaceutical cocrystals on the few nanometer scale. Moreover, the result explains that caffeine and oxalic acid cocrystallize layer by layer on the surface of mesoporous silica. These bottom-up processes will open the way to precisely control the size of cocrystals in porous materials, and to improve the bioavailability of various kinds of pharmaceuticals.
Experimental

Reagents and samples
We prepared pellets of caffeine, oxalic acid, and their cocrystals. Each of them was synthesized with or without SBA-16. Caffeine, oxalic acid, and their cocrystals incorporated in SBA-16 were synthesized as follows. Caffeine (Tokyo Chemical Industry Co., Ltd., 810 mg) and anhydrous oxalic acid (Wako Pure Chemical Industries, Ltd., 180 mg) were dissolved in a mixture of chloroform (Kanto Chemical Co., Inc., 11.7 mL) and methanol (Kanto Chemical Co., Inc., 3.3 mL). The caffeine and oxalic acid were used without further purification. The solution was stirred for 20 min at 330 K. The molar ratio of caffeine to oxalic acid was set to two in the solvent. The solution of caffeine and that of oxalic acid were also prepared in the same manner. Figure 1(a) shows the solutions of caffeine, oxalic acid, and the mixture of caffeine and oxalic acid at room temperature. Caffeine and oxalic acid were dissolved in the solvent. However, the mixture of caffeine and oxalic acid caused the precipitation of their cocrystals because they form caffeine-oxalic acid cocrystals as the temperature is decreased.
As a reference for Raman spectroscopy, caffeine-oxalic acid cocrystals without SBA-16 were synthesized from a solution containing caffeine and oxalic acid by employing rotoevaporation and vacuum filtration.
Cubic symmetrical SBA-16 was synthesized in the same manner as in Ref. 32 . Figure 1(b) shows a transmission electron microscope (TEM) image of cubic symmetrical SBA-16. SBA-16 was calcinated by slowly increasing the temperature from room temperature to 720 K, and keeping it at 720 K for 6 h so as to reduce moisture in the pores. A fifty-milligramportion of SBA-16 was soaked in 50 μL of each solution, which contained 13.4-μmol-caffeine or 6.7-μmol-oxalic acid. After vigorous stirring of the mixtures, the solvents were evaporated at 350 K. The soaking, stirring, and evaporating were repeated from 1 to 14 times so as to synthesize caffeine-oxalic acid cocrystals in SBA-16 at different molar amounts. The remaining solvents were cleaned in a vacuum oven at 310 K for 30 min. All materials were compressed at 20 kgf/cm 2 for 1 min to form pellets with a 5-mm diameter. The pellet form is very suitable for Raman spectroscopy, because its flat surface enables us to keep the laser focused at different positions and to reproduce the measurements.
Apparatus
Samples were evaluated by a micro Raman spectroscopy system (in Via Reflex Raman Microscope, Renishaw). The excitation light source was a continuous-wave laser diode with 785-nm wavelength (NIR, Renishaw). The laser light was focused on the sample surface by an objective lens (Plan Apo ×50, Leica). The focal spot of the laser beam was about 2 μm in diameter. Raman scatterings were collected by the same objective lens and passed through Rayleigh filters. Raman spectra were acquired by a single spectrometer, whose focal length and diffraction grating groove density were 250 mm and 1800 line/mm, respectively, which provided a spectral resolution of 2 cm -1 . Samples were under atmosphere pressure at room temperature. We took 49 spectra for each sample at different positions in a 350 × 350 μm area so as to compensate for any position variability. Nine deviated spectra were removed, and the 40 remaining spectra were averaged to obtain the spectrum for each sample. All Raman spectra were taken in 30 s from 10 to 2000 cm -1 . Figure 2 shows wide-range Raman spectra of (a) caffeine, (b) oxalic acid, and (c) caffeine-oxalic acid cocrystals with that of SBA-16 as dashed curves. The peak frequencies of the spectra represent the vibrational mode frequencies of the intermolecular and intramolecular bonds. The Raman spectra of caffeine, oxalic acid, and their cocrystals lower than 400 cm -1 are clearly different because the cocrystals consist of caffeine-oxalic acid intermolecular bonds instead of caffeine-caffeine bonds and oxalic acid-oxalic acid bonds. 5 On the other hand, the spectrum of the intramolecular bonds in cocrystals above 400 cm -1 is similar to that of caffeine. However, the peak frequencies of the two spectra are slightly different. For example, the Raman spectrum of caffeine has a peak at 554 cm -1 , whereas that of cocrystals has a peak at 550 cm -1 . This is because the intermolecular bonds of caffeine and oxalic acid modify the electron distribution of the intramolecular bonds in caffeine. These peak frequency shifts can represent weak intermolecular interactions, which are not strong enough to cause Raman peaks in the low-frequency region. Since the Raman spectrum of SBA-16 has no remarkable peaks in this frequency region, we attribute it to background. Figure 3 show the Raman spectra shifts of (a) cocrystal, (b) oxalic acid, and (c) caffeine with and without SBA-16. The molar amounts of cocrystal (caffeine/oxalic acid), oxalic acid, and caffeine are 84/42, 70, and 28 μmol for 50 mg of SBA-16, respectively. Each vibrational mode is slightly modified when the molecules are trapped in SBA-16 because the intermolecular interactions from SBA-16 modify the electron distribution of the intra-and inter-molecules. In Fig. 3(a) , the peak frequencies at 32, 56, and 83 cm -1 are slightly red-shifted when the cocrystals are synthesized in SBA-16. These peak shifts indicate that the cocrystals are dominantly synthesized on the surface of SBA-16 without aggregation at these molar amounts. The spectra of oxalic acid and caffeine are also varied by SBA-16 as shown in Figs. 3(b) and 3(c) . The Raman peaks of oxalic acid with SBA-16 become red-shifted with peak broadening, while those of caffeine with SBA-16 become blue-shifted from that of the original peaks. These frequency shifts confirm the incorporation of molecules in SBA-16 during crystallization, and that molecular crystals form without clustering at those molar amounts.
Results and Discussion
For a more detailed discussion about the synthesis mechanism of cocrystal in SBA-16, we focus on the Raman spectra from 530 to 670 cm -1 . In this range, two peaks originating from the intramolecular bonds of δ(CNC) and δ(OCN) in a caffeine molecule are observed in caffeine crystals and caffeine-oxalic acid cocrystals. [22] [23] [24] These two peaks change their frequencies and bandwidths when caffeine crystals and cocrystals are incorporated in SBA-16, as shown in Fig. 4 and Table 1 . In particular, the two peaks of the cocrystals with SBA-16 asymmetrically deform from their original shapes. These asymmetric peaks imply that the Raman spectrum of the cocrystal with SBA-16 can be divided into three spectra originating from the cocrystal without SBA-16, caffeine with SBA-16, and caffeine without SBA-16. The relative Raman intensity of the three components at each molar amount reveals the dynamics of the surrounding caffeine molecules during cocrystallization in SBA-16. On the other hand, the Raman spectra of oxalic acid in its cocrystals are too weak to distinguish their different states. The molar amount of oxalic acid is half that of caffeine, as described in Experimental. Figure 5 show the Raman spectra of the cocrystals with SBA-16 (black) and the curve fitted by the four spectra (pink) Fig. 2 Raman spectra of (a) caffeine, (b) oxalic acid, and (c) their cocrystals with that of SBA-16 (dashed lines). Each spectrum is the average of the 40 spectra taken for each sample at different points. Figure 6(a) shows the relative peak intensities of each component at various molar amounts, which explains the synthesis of caffeine-oxalic acid cocrystals in SBA-16. This process can be categorized into two situations. When the amount of caffeine is less than 67 μmol (A), the peak intensity of caffeine with SBA-16 linearly increases, while that of the cocrystals does not change, which indicates that caffeine and oxalic acid are respectively captured on the surface of SBA-16. They form monolayers on the surface of SBA-16 without aggregation, as schematically shown in Fig. 6(b) . At around 67 μmol, the peak intensity of caffeine with SBA-16 saturates, which indicates that the surface of SBA-16 is fully occupied by caffeine and oxalic acid, as shown in Fig. 6(c) . The molecular density on the surface of SBA-16 is about 1.19 nm -2 , which is estimated from the surface area of SBA-16 of 750 m 2 /g. 14, 15 The molecular density is on the order of that in a previous report on aromatic carboxylic acids in SBA-16.
14,15 After the saturation of caffeine with SBA-16 (B), the peak intensity of cocrystals without SBA-16 increases together with that of caffeine without SBA-16. This indicates that cocrystals are synthesized on the monolayer caffeine and oxalic acid and stacked layer by layer without aggregating as shown in Fig. 6(d) . Thanks to the large surface area of SBA-16, the growth rate is slow enough to control the thickness for few-nanometer-scale cocrystals. Moreover, bi-layer, and tri-layer cocrystals can be synthesized by choosing appropriate molar amounts of caffeine and oxalic acid. In this case, the amounts of 134 and 201 μmol will provide bi-layer and tri-layer cocrystals. The precise control of thin-layered cocrystals will improve the bioavailabilities of pharmaceuticals.
Conclusions
We demonstrated the Raman spectroscopic analysis of caffeine-oxalic acid cocrystals incorporated in nanosized pores of SBA-16. Peak resolving analysis describes the adsorption of molecules on the surfaces of the pores and their cocrystallization layer by layer. These bottom-up processes with porous material can be widely applied to other compound molecular crystals, and Raman spectroscopy will reveal the formation of nanometer-scale cocrystals. We believe that these techniques will provide designed solubility of pharmaceuticals, and lead to more efficient drug-delivery systems.
